Language
FDA advisers vote against Lexicon Pharma's add-on drug for type 1 diabetes | Reuters

Blog

HomeHome / Blog / FDA advisers vote against Lexicon Pharma's add-on drug for type 1 diabetes | Reuters
search

Jun 26, 2023

Cuyuna Rock Club agate and mineral show set May 13

Jun 24, 2023

FREMONT ANNOUNCES: Signs Agreement on Vardenis Property in Armenia; Acquires Historic Data from Dundee Precious Metals; Applies for Exploration License over Urasar Mineral District in Northern Armenia

Aug 02, 2023

Neem leaf powder (Azadirachta indica) mitigates oxidative stress and pathological alterations triggered by lead toxicity in Nile tilapia (Oreochromis niloticus)

Oct 09, 2023

Ginkgo Bioworks and Centrient Pharmaceuticals Announce Expansion of Partnership Following Success of Initial Project to Bring Sustainable Innovation to the Generic API Space

Oct 18, 2023

Univar Solutions Expands Specialty Pharmaceutical and Nutraceutical Ingredient Portfolios with Grace SYLOID® FP Silica for Majority of Europe

Send your inquiry
SUBMIT

Nov 02, 2024

FDA advisers vote against Lexicon Pharma's add-on drug for type 1 diabetes | Reuters

Sign up here. Reporting by Sneha S K and Sruthi Narasimha Chari in Bengaluru; Editing by Shailesh Kuber and Maju Samuel Our Standards: The Thomson Reuters Trust Principles., opens new tab

Sign up here.

Reporting by Sneha S K and Sruthi Narasimha Chari in Bengaluru; Editing by Shailesh Kuber and Maju Samuel

Our Standards: The Thomson Reuters Trust Principles., opens new tab